Grant Pickering, CHIEF EXECUTIVE OFFICER at Vaxcyte, Inc. (PCVX), sold 30,000 shares at $93.06 ($2.8M) on 2024-12-02, disclosed to the SEC on 2024-12-03.
Scheduled sale ($2.8M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $92.06 | 11,349 | $1.0M | 37.7% |
| 2 | $92.06 | 11,349 | $1.0M | 37.7% |
| 3 | $93.06 | 1,409 | $131K | 4.7% |
| 4 | $93.06 | 1,409 | $131K | 4.7% |
| 5 | $94.06 | 2,242 | $211K | 7.6% |
| 6 | $94.06 | 2,242 |
| $211K |
| 7.6% |
| Total | $92.45 avg | 30,000 | $2.8M | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $1.2M | — | Filing → |
| PCVX | SELL | 2024-12-10 | $401K | — | Filing → |
| PCVX | SELL | 2024-11-08 | $246K | — | Filing → |